Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2018

01-01-2018 | Letter to the Editor

Prognostic effect of neutrophil–lymphocyte ratio during concurrrent chemo-radiotherapy period in glioblastoma patients who did not receive dexamethasone

Author: Kadri Altundag

Published in: Journal of Neuro-Oncology | Issue 1/2018

Login to get access

Excerpt

To the Editor, …
Literature
1.
go back to reference Mason M, Maurice C, McNamara MG, Tieu MT, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Atenafu EG, Mason W, Chung C (2017) Neutrophil–lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival. J Neurooncol. doi:10.1007/s11060-017-2395-y PubMed Mason M, Maurice C, McNamara MG, Tieu MT, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Atenafu EG, Mason W, Chung C (2017) Neutrophil–lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival. J Neurooncol. doi:10.​1007/​s11060-017-2395-y PubMed
2.
go back to reference Ruiz LM, Bedoya G, Salazar J, de Garcia OD, Patino PJ (2002) Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species. Inflammation 26(5):215–222CrossRefPubMed Ruiz LM, Bedoya G, Salazar J, de Garcia OD, Patino PJ (2002) Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species. Inflammation 26(5):215–222CrossRefPubMed
Metadata
Title
Prognostic effect of neutrophil–lymphocyte ratio during concurrrent chemo-radiotherapy period in glioblastoma patients who did not receive dexamethasone
Author
Kadri Altundag
Publication date
01-01-2018
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2645-z

Other articles of this Issue 1/2018

Journal of Neuro-Oncology 1/2018 Go to the issue